# US 2023/0143042 A1 · System and method for aerosol particle production of submicron and nano structured materials

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0143042 A1
- Document ID: US20230143042A1
- Status: Published application
- Kind: A1
- Application number: 17/917,598
- Filed: 2021-04-06
- Published: 2023-05-11
- Earliest claimed: 2020-04-07
- Assignees: The Trustees of Princeton University
- Applicants: The Trustees of Princeton University
- Inventors: Maksym MEZHERICHER; Howard A. STONE
- Web page: https://patentgrep.com/patent/US20230143042A1

## CPC

- A61M 11/02: operated by air {or other gas} pressure applied to the liquid {or other product} to be sprayed or atomised {(sprayers for horticulture A01G, A01H; killing insects A01M; air humidifying by nozzles F24F6/14, F24F6/18; cooling by spraying F28B, F28C)}
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A23L 35/10: {Emulsified foodstuffs}
- A61K 31/58: containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin (digitoxin {A61K31/7048})
- A61K 47/02: Inorganic compounds
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61M 16/14: by mixing different fluids, one of them being in a liquid phase
- B01J 13/0095: {Preparation of aerosols}
- A23L 33/115: Fatty acids or derivatives thereof; Fats or oils
- A23L 33/15: Vitamins
- A23L 33/155: Vitamins A or D
- A61K 35/76: Viruses; Subviral particles; Bacteriophages
- A61K 36/3482: {Cannabis}
- A61M 2202/0468: non-physiological
- A61M 2202/206: Viruses
- A61M 2202/30: Vaccines
- A61M 2205/3331: Pressure; Flow
- A61M 2205/3379: Masses, volumes, levels of fluids in reservoirs, flow rates
- A61M 2205/3606: cooled
- A61M 2205/50: with microprocessors or computers
- A61M 2209/02: Equipment for testing the apparatus
- A61P 11/00: Drugs for disorders of the respiratory system
- B05B 7/0012: {Apparatus for achieving spraying before discharge from the apparatus}
- B05B 7/2489: {an atomising fluid, e.g. a gas, being supplied to the discharge device (B05B7/2402, B05B7/2483, B05B7/262 take precedence)}
- B05B 17/06: using ultrasonic {or other kinds of} vibrations
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- B05B: SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES (spray-mixers with nozzles B01F25/72; processes for applying liquids or other fluent materials to surfaces by spraying B05D)

## Abstract

Disclosed herein is a multi-purpose aerosol platform capable of producing and delivery of submicron and nano structured materials for pharmaceutical, biomedical and environmental applications. Depending on the application, active chemical and biological materials may be processed from liquid dispersions into droplets and/or particle formulations. The disclosed system uses moderate gas pressures to atomize liquids into submicron-size droplets that are 10-1000 times smaller in diameter than commercial and research systems. This allows much gentler and rapid droplet-to-particle conversion, applying much smaller physical and chemical stresses on the processed materials than conventional techniques like spray drying, spray coating, spray freeze drying and other technologies. For example, the disclosed system can be used for an ultra-fine nebulization and delivery of viscous therapeutic oils including oils of medical cannabis, for which conventional nebulization systems either fail or became ineffective. Such systems could help patients with acute respiratory distress syndrome (ARDS) developed in hard COVID-19 cases.

## Claims

### Claim 1

A method for creating aerosols of droplets, aerosols of particles, or powders, comprising:
providing a liquid comprising a dispersed active chemical or biological material;
aerating the liquid in an atomization chamber to form bubbles, such that the bubbles rise to a surface of the liquid;
forming a submicron droplet aerosol by causing a gas jet to be directed through an opening in a tube towards at least one of the bubbles in the atomization chamber;
optionally forming a dry particle aerosol via solvent evaporation of the submicron droplet aerosol; and
optionally forming a powder of submicron or nano-structured particles by passing the dry particle aerosol through a particle collector.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the dispersed active chemical or biological material comprises a bacteriophage or an active pharmaceutical ingredient (API).

### Claim 3 (depends on 1)

The method according to claim 1, wherein a pressure of a gas provided to the tube in order to cause the gas jets is based on a viscosity of the liquid.

### Claim 4 (depends on 1)

The method according to claim 1, wherein a viscosity of the liquid is between 5 and 1000 times the viscosity of water.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the solvent evaporation involves subjecting the droplet aerosol a gas having a temperature between 0° C. and 120° C.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the solvent evaporation step includes lyophilization.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the submicron droplet aerosol or dry particle aerosol is then provided to a patient.

### Claim 8 (depends on 7)

The method according to claim 7, wherein the patient is being treated with a ventilation machine, and the submicron droplet aerosol or dry particle aerosol is introduced in-line with the ventilation machine.

### Claim 9

A system for creating aerosols of droplets, aerosols of particles, or powders, comprising:
an atomization chamber;
a tube within the atomization chamber, the tube configured to be partially submerged in a liquid, the tube comprising openings through a side wall of the tube, the openings arranged such that at least some openings are configured to direct a gas jet towards a bubble on a surface of the liquid to form a submicron droplet aerosol, the liquid containing a dispersed active chemical or biological material;
optionally, at least one chamber configured to form a dry particle aerosol via solvent evaporation of the submicron droplet aerosol; and
optionally, a particle collector configured to collect dry particles from the dry particle aerosol.

### Claim 10 (depends on 9)

The system according to claim 9, wherein the dispersed active chemical or biological material comprises a bacteriophage or an active pharmaceutical ingredient (API).

### Claim 11 (depends on 9)

The system according to claim 9, wherein an air pressure of the gas jet is based on a viscosity of the liquid.

### Claim 12 (depends on 9)

The system according to claim 9, wherein a viscosity of the liquid is between 5 and 1000 times the viscosity of water.

### Claim 13 (depends on 9)

The system according to claim 9, wherein the at least one chamber is configured to subject the submicron droplet aerosol to a gas having a temperature between 0° C. and 120° C.

### Claim 14 (depends on 9)

The system according to claim 9, wherein the at least one chamber is configured to subject the submicron droplet aerosol to lyophilization.

### Claim 15 (depends on 9)

The system according to claim 9, wherein the submicron droplet aerosol or dry particle aerosol is configured to be introduced in-line with a ventilation machine.
